July 12, 2023
FIRM Chair Yoshitsugu Shitaka Japan urgently needs to review its pricing and regulatory systems surrounding regenerative medical products if the country wants to stave off drug lags and losses, says the Forum for Innovative Regenerative Medicine (FIRM). FIRM Chair Yoshitsugu...read more